Eliminating human tuberculosis in the twenty-first century

被引:138
作者
Dye, Christopher [1 ]
Williams, Brian G. [1 ]
机构
[1] WHO, HIV AIDS Tuberculosis & Malaria, CH-1211 Geneva 27, Switzerland
关键词
diagnostics; drugs; vaccines; latent infection; cost-effectiveness;
D O I
10.1098/rsif.2007.1138
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Recognizing that tuberculosis ( TB) is still the leading cause of human death from a curable infection, the international health community has set ambitious targets for disease control. One target is to eliminate TB by 2050; that is, to cut the annual incidence of new cases to less than 1 per million population. National TB control programmes are working to eliminate TB mainly by intensifying efforts to find and cure patients with active disease. Here, we use mathematical modelling to show that, while most TB patients can be cured with present drug regimens, the 2050 target is far more likely to be achieved with a combination of diagnostics, drugs and vaccines that can detect and treat both latent infection and active disease. We find that the coupling of control methods is particularly effective because treatments for latent infection and active disease act in synergy. This synergistic effect offers new perspectives on the cost-effectiveness of treating latent TB infection and the impact of possible new TB vaccines. Our results should be a stimulus to those who develop, manufacture and implement new technology for TB control, and to their financial donors.
引用
收藏
页码:653 / 662
页数:10
相关论文
共 43 条
[1]   The success and failure of BCG - implications for a novel tuberculosis vaccine [J].
Andersen, P ;
Doherty, TM .
NATURE REVIEWS MICROBIOLOGY, 2005, 3 (08) :656-662
[2]   The prognosis of latent tuberculosis: can disease be predicted [J].
Andersen, Peter ;
Doherty, T. Mark ;
Pai, Madhukar ;
Weldingh, Karin .
TRENDS IN MOLECULAR MEDICINE, 2007, 13 (05) :175-182
[3]  
ANDERSON R M, 1991
[4]  
[Anonymous], 2001, Wkly Epidemiol Rec, V76, P33
[5]   Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis [J].
Aziz, Mohamed Abdel ;
Wright, Abigail ;
Laszlo, Adalbert ;
De Muynck, Aime ;
Portaels, Francois ;
Van Deun, Armand ;
Wells, Charles ;
Nunn, Paul ;
Blanc, Leopold ;
Raviglione, Mario .
LANCET, 2006, 368 (9553) :2142-2154
[6]   THE INTRINSIC TRANSMISSION DYNAMICS OF TUBERCULOSIS EPIDEMICS [J].
BLOWER, SM ;
MCLEAN, AR ;
PORCO, TC ;
SMALL, PM ;
HOPEWELL, PC ;
SANCHEZ, MA ;
MOSS, AR .
NATURE MEDICINE, 1995, 1 (08) :815-821
[7]   Control strategies for tuberculosis epidemics: New models for old problems [J].
Blower, SM ;
Small, PM ;
Hopewell, PC .
SCIENCE, 1996, 273 (5274) :497-500
[8]   New measurable indicator for tuberculosis case detection [J].
Borgdorff, MW .
EMERGING INFECTIOUS DISEASES, 2004, 10 (09) :1523-1528
[9]   The effect of drug resistance on the fitness of Mycobacterium tuberculosis [J].
Cohen, T ;
Sommers, B ;
Murray, M .
LANCET INFECTIOUS DISEASES, 2003, 3 (01) :13-21
[10]  
COHN DL, 2000, LUNG BIOL HEALTH DIS, V144, P471